Agios Pharmaceuticals (AGIO)

$36.16 +1.16 (3.31%)
Market Cap 2.03B
Revenue (ttm) 36.50M
Net Income (ttm) 673.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1,845.84%
Debt to Equity Ratio 0.00
Volume 5,497,000
Avg Vol 683,896
Day's Range N/A - N/A
Shares Out 57.92M
Stochastic %K 9%
Beta 0.80
Analysts Strong Sell
Price Target $49.86

Company Profile

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatr...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 649 8600
Address:
88 Sidney Street, Cambridge, United States
RunnerSignals
RunnerSignals Aug. 4 at 8:41 PM
comeback vibes today $CORT $DPRO $AGIO $YMM $LC all dipped hard midday but bounced back stronger at the close
0 · Reply
theflynews
theflynews Aug. 4 at 8:29 PM
What You Missed On Wall Street On Monday - $AGIO - https://thefly.com/permalinks/entry.php/AGIOid4174433?1754338990C38
0 · Reply
jotu
jotu Aug. 4 at 6:16 PM
$AGIO Would never have believed such a fast rebound was possible after 4 deaths. $SRPT
1 · Reply
The_Fudster
The_Fudster Aug. 4 at 6:09 PM
$AGIO must. resist. urge. to. go. dumpster. diving.
1 · Reply
Mamma_m1a
Mamma_m1a Aug. 4 at 6:03 PM
$AGIO Bearish Form 8-k https://www.sec.gov/Archives/edgar/data/1439222/000143922225000090/agio-20250804.htm
1 · Reply
_www_larval_com_
_www_larval_com_ Aug. 4 at 5:58 PM
$AGIO has turned 3% higher to -10% (~2Mv) a moment ago, 08/15 options, follow for more volatility.
0 · Reply
UgoGreg
UgoGreg Aug. 4 at 2:42 PM
$AGIO https://youtu.be/adEGltVmxtc
0 · Reply
Dkll303
Dkll303 Aug. 4 at 2:27 PM
$AGIO 9 times the daily volume at this hour is : FCUK YOU GOFF…SELLING
0 · Reply
Dkll303
Dkll303 Aug. 4 at 2:23 PM
$AGIO 7 months later, Goff burns buyers again You suckers since Jan 2025
0 · Reply
DayTradingPredictions
DayTradingPredictions Aug. 4 at 2:20 PM
$AGIO AGIO
0 · Reply
Latest News on AGIO
Agios' PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

Aug 4, 2025, 4:01 PM EDT - 3 hours ago

Agios' PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

Agios Pharmaceuticals, Inc. (AGIO) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 5:02 PM EDT - 4 days ago

Agios Pharmaceuticals, Inc. (AGIO) Q2 2025 Earnings Call Transcript

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 31, 2025, 6:30 AM EDT - 4 days ago

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET

Jul 14, 2025, 7:00 AM EDT - 21 days ago

Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET

Agios Appoints Dr. Jay Backstrom to Board of Directors

Jul 8, 2025, 7:00 AM EDT - 27 days ago

Agios Appoints Dr. Jay Backstrom to Board of Directors

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders

Jun 9, 2025, 8:40 AM EDT - 2 months ago

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders

Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025

May 28, 2025, 7:00 AM EDT - 2 months ago

Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025

Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress

May 14, 2025, 10:00 AM EDT - 2 months ago

Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

May 9, 2025, 7:00 AM EDT - 3 months ago

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025

May 2, 2025, 7:00 AM EDT - 3 months ago

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025

Agios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call Transcript

May 1, 2025, 12:06 PM EDT - 3 months ago

Agios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call Transcript

Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 1, 2025, 6:30 AM EDT - 3 months ago

Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

Apr 17, 2025, 7:00 AM EDT - 3 months ago

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

Mar 5, 2025, 5:52 PM EST - 5 months ago

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

Agios to Present at Upcoming Investor Conferences

Mar 4, 2025, 7:00 AM EST - 5 months ago

Agios to Present at Upcoming Investor Conferences

Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025

Feb 20, 2025, 7:00 AM EST - 5 months ago

Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025

Agios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 1:32 PM EST - 6 months ago

Agios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call Transcript

Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Feb 13, 2025, 6:31 AM EST - 6 months ago

Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Agios' Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint

Feb 13, 2025, 6:30 AM EST - 6 months ago

Agios' Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint

Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

Feb 6, 2025, 7:00 AM EST - 6 months ago

Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer

Jan 8, 2025, 8:00 AM EST - 7 months ago

Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer

BIIB

Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Jan 3, 2025, 7:00 AM EST - 7 months ago

Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease

Dec 18, 2024, 7:00 AM EST - 8 months ago

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat

Dec 8, 2024, 12:40 PM EST - 8 months ago

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition

Nov 5, 2024, 9:05 AM EST - 9 months ago

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition

Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 2:16 PM EDT - 9 months ago

Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript

Agios Reports Business Highlights and Third Quarter 2024 Financial Results

Oct 31, 2024, 6:30 AM EDT - 9 months ago

Agios Reports Business Highlights and Third Quarter 2024 Financial Results

Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024

Oct 17, 2024, 7:00 AM EDT - 10 months ago

Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024

Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)

Sep 11, 2024, 7:00 AM EDT - 11 months ago

Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)

Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024

Sep 5, 2024, 7:00 AM EDT - 11 months ago

Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024

Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment

Aug 27, 2024, 10:18 AM EDT - 1 year ago

Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment

Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib

Aug 6, 2024, 5:50 PM EDT - 1 year ago

Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib

Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides

Aug 1, 2024, 1:42 PM EDT - 1 year ago

Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides

Agios Pharmaceuticals, Inc. (AGIO) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 12:11 PM EDT - 1 year ago

Agios Pharmaceuticals, Inc. (AGIO) Q2 2024 Earnings Call Transcript

Agios Reports Business Highlights and Second Quarter 2024 Financial Results

Aug 1, 2024, 6:31 AM EDT - 1 year ago

Agios Reports Business Highlights and Second Quarter 2024 Financial Results

Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused

Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024

Jul 18, 2024, 7:00 AM EDT - 1 year ago

Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024

Agios Pharmaceuticals: Potential Acquisition Target, Upcoming FDA Approvals, Promising Pipeline

Jun 12, 2024, 7:41 AM EDT - 1 year ago

Agios Pharmaceuticals: Potential Acquisition Target, Upcoming FDA Approvals, Promising Pipeline

Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study

Jun 3, 2024, 6:42 AM EDT - 1 year ago

Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study

Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Jun 3, 2024, 6:30 AM EDT - 1 year ago

Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 30, 2024, 4:05 PM EDT - 1 year ago

Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress

May 14, 2024, 10:00 AM EDT - 1 year ago

Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024

May 3, 2024, 7:00 AM EDT - 1 year ago

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024

Agios Pharmaceuticals, Inc. (AGIO) Q1 2024 Earnings Call Transcript

May 2, 2024, 4:32 PM EDT - 1 year ago

Agios Pharmaceuticals, Inc. (AGIO) Q1 2024 Earnings Call Transcript

Agios Reports Business Highlights and First Quarter 2024 Financial Results

May 2, 2024, 7:00 AM EDT - 1 year ago

Agios Reports Business Highlights and First Quarter 2024 Financial Results

Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024

Apr 18, 2024, 7:00 AM EDT - 1 year ago

Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024

Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024

Mar 5, 2024, 7:00 AM EST - 1 year ago

Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024

Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024

Feb 22, 2024, 7:00 AM EST - 1 year ago

Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024

Agios Pharmaceuticals (AGIO) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 2:08 PM EST - 1 year ago

Agios Pharmaceuticals (AGIO) Q4 2023 Earnings Call Transcript

Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Feb 15, 2024, 7:00 AM EST - 1 year ago

Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

RunnerSignals
RunnerSignals Aug. 4 at 8:41 PM
comeback vibes today $CORT $DPRO $AGIO $YMM $LC all dipped hard midday but bounced back stronger at the close
0 · Reply
theflynews
theflynews Aug. 4 at 8:29 PM
What You Missed On Wall Street On Monday - $AGIO - https://thefly.com/permalinks/entry.php/AGIOid4174433?1754338990C38
0 · Reply
jotu
jotu Aug. 4 at 6:16 PM
$AGIO Would never have believed such a fast rebound was possible after 4 deaths. $SRPT
1 · Reply
The_Fudster
The_Fudster Aug. 4 at 6:09 PM
$AGIO must. resist. urge. to. go. dumpster. diving.
1 · Reply
Mamma_m1a
Mamma_m1a Aug. 4 at 6:03 PM
$AGIO Bearish Form 8-k https://www.sec.gov/Archives/edgar/data/1439222/000143922225000090/agio-20250804.htm
1 · Reply
_www_larval_com_
_www_larval_com_ Aug. 4 at 5:58 PM
$AGIO has turned 3% higher to -10% (~2Mv) a moment ago, 08/15 options, follow for more volatility.
0 · Reply
UgoGreg
UgoGreg Aug. 4 at 2:42 PM
$AGIO https://youtu.be/adEGltVmxtc
0 · Reply
Dkll303
Dkll303 Aug. 4 at 2:27 PM
$AGIO 9 times the daily volume at this hour is : FCUK YOU GOFF…SELLING
0 · Reply
Dkll303
Dkll303 Aug. 4 at 2:23 PM
$AGIO 7 months later, Goff burns buyers again You suckers since Jan 2025
0 · Reply
DayTradingPredictions
DayTradingPredictions Aug. 4 at 2:20 PM
$AGIO AGIO
0 · Reply
Dkll303
Dkll303 Aug. 4 at 2:17 PM
$AGIO yes ..the mole got the info
0 · Reply
Dkll303
Dkll303 Aug. 4 at 2:14 PM
$AGIO $KRYS $TGTX $TWST no mgmt lies here HUGE at AGIO
0 · Reply
Chomo
Chomo Aug. 4 at 2:03 PM
$AGIO $TGTX $KRYS $TWST those bios are bleeding hard.
0 · Reply
Dkll303
Dkll303 Aug. 4 at 1:52 PM
$AGIO GOFF 3 years on the dole at AGIOS and his NEGATIVE ROI !! Misfits !! Losers !! John Maraganore knew it and left !
0 · Reply
Dkll303
Dkll303 Aug. 4 at 1:51 PM
$AGIO FOUSE REGIME and still on Board , lol NEGATIVE 65%
0 · Reply
Dkll303
Dkll303 Aug. 4 at 1:48 PM
$AGIO GOFF came on 8/2022 At $29.38 He has done CRAP for this company FOUSE in 7 years has taken ROI NEGATIVE 65% !!! What a duo !!! Losers
0 · Reply
Dkll303
Dkll303 Aug. 4 at 1:47 PM
$AGIO 400,000 shares by 9:45 in this symbol is Unusual dumping Clearly , those in the know are dumping , their mole has news that isn’t out yet !! NOT RETAIL , FUNDS and Hedge Funds !!
0 · Reply
Dkll303
Dkll303 Aug. 4 at 1:40 PM
$AGIO The failures continue at AGIOS !! Never ends here….FOUSE for 7 years would kill any business model Goff…just a puppet
0 · Reply
Tumble51
Tumble51 Aug. 4 at 1:37 PM
$AGIO NEW YEAR LOW COMING CANTOR FITZ BLOWS ANOTHER BIOTECH Outperform, hahahaha …FAILURE AT CANTOR
0 · Reply
Tumble51
Tumble51 Aug. 4 at 1:36 PM
$AGIO 3 days of SELLING ..is FUNDS DUMPING THIS POS !
0 · Reply
Tumble51
Tumble51 Aug. 4 at 1:35 PM
$AGIO you called it !! 👏👏👏👏
0 · Reply
Tumble51
Tumble51 Aug. 4 at 1:34 PM
$AGIO $20’s already !!
0 · Reply